{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:12:17Z","timestamp":1778721137092,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M751137"],"award-info":[{"award-number":["2024M751137"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A04J3241"],"award-info":[{"award-number":["2025A04J3241"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["21624352"],"award-info":[{"award-number":["21624352"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404418"],"award-info":[{"award-number":["82404418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["CCNU25JC037"],"award-info":[{"award-number":["CCNU25JC037"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005234","name":"Central China Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109869","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:07:49Z","timestamp":1776233269000},"page":"109869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-based design of the approved drug zafirlukast identifies HLC40 as a potent WDR5 WIN-site inhibitor with antitumor efficacy"],"prefix":"10.1016","volume":"176","author":[{"given":"Linchong","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congzhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juqi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinrong","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinghua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2026.109869_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0968-0004(99)01384-5","article-title":"The WD repeat: a common architecture for diverse functions","volume":"24","author":"Smith","year":"1999","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109869_bb0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.tibs.2010.04.003","article-title":"WD40 proteins propel cellular networks","volume":"35","author":"Stirnimann","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7020021","article-title":"Moonlighting with WDR5: a cellular multitasker","volume":"7","author":"Guarnaccia","year":"2018","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109869_bb0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s13238-011-1018-1","article-title":"Structure and function of WD40 domain proteins","volume":"2","author":"Xu","year":"2011","journal-title":"Protein Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109869_bb0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nsmb1128","article-title":"Regulation of MLL1 H3K4 methyltransferase activity by its core components","volume":"13","author":"Dou","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"36","key":"10.1016\/j.bioorg.2026.109869_bb0030","doi-asserted-by":"crossref","first-page":"24242","DOI":"10.1074\/jbc.M109.014498","article-title":"On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex","volume":"284","author":"Patel","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109869_bb0035","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1093\/nar\/gkr1235","article-title":"The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases","volume":"40","author":"Zhang","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109869_bb0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nsmb1119","article-title":"Histone h3 recognition and presentation by the WDR5 module of the MLL1 complex","volume":"13","author":"Ruthenburg","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109869_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nchembio.1859","article-title":"Pharmacological targeting of the Wdr5-MLL interaction in C\/EBP\u03b1 n-terminal leukemia","volume":"11","author":"Grebien","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"43","key":"10.1016\/j.bioorg.2026.109869_bb0050","doi-asserted-by":"crossref","first-page":"32967","DOI":"10.1074\/jbc.M110.159921","article-title":"Characterization of a novel WDR5-binding site that recruits RbBP5 through a conserved motif to enhance methylation of histone h3 lysine 4 by mixed lineage leukemia protein-1","volume":"285","author":"Odho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109869_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu. Rev. Biochem."},{"issue":"47","key":"10.1016\/j.bioorg.2026.109869_bb0060","doi-asserted-by":"crossref","first-page":"32158","DOI":"10.1074\/jbc.C800164200","article-title":"Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide","volume":"283","author":"Patel","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.bioorg.2026.109869_bb0065","doi-asserted-by":"crossref","first-page":"32162","DOI":"10.1074\/jbc.M806317200","article-title":"A conserved arginine-containing motif crucial for the assembly and enzymatic activity of the mixed lineage leukemia protein-1 core complex","volume":"283","author":"Patel","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.bioorg.2026.109869_bb0070","doi-asserted-by":"crossref","first-page":"22357","DOI":"10.1074\/jbc.M116.752626","article-title":"Targeted disruption of the interaction between WD-40 repeat protein 5 (WDR5) and mixed lineage leukemia (MLL)\/SET1 family proteins specifically inhibits MLL1 and SETd1A methyltransferase complexes","volume":"291","author":"Alicea-Vel\u00e1zquez","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109869_bb0075","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1101\/gad.240200.114","article-title":"Structural analysis of the KANSL1\/WDR5\/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex","volume":"28","author":"Dias","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2026.109869_bb0080","article-title":"Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109869_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13046-021-01989-5","article-title":"Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.bioorg.2026.109869_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168773","article-title":"The Wdr5-H3K4me3 epigenetic axis regulates pancreatic tumor immunogenicity and immune suppression","volume":"25","author":"Deng","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109869_bb0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1186\/s12885-018-4580-6","article-title":"WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage","volume":"18","author":"Neilsen","year":"2018","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109869_bb0100","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.7150\/ijbs.69454","article-title":"The lncRNA BDNF-AS\/WDR5\/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination","volume":"18","author":"Huang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"25","key":"10.1016\/j.bioorg.2026.109869_bb0105","doi-asserted-by":"crossref","first-page":"37740","DOI":"10.18632\/oncotarget.9312","article-title":"WDR5 high expression and its effect on tumorigenesis in leukemia","volume":"7","author":"Ge","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109869_bb0110","doi-asserted-by":"crossref","first-page":"16008","DOI":"10.1038\/celldisc.2016.8","article-title":"MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program","volume":"2","author":"Xu","year":"2016","journal-title":"Cell Discov."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109869_bb0115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0092-8674(92)90602-9","article-title":"Involvement of a homolog of drosophila trithorax by 11q23 chromosomal translocations in acute leukemias","volume":"71","author":"Tkachuk","year":"1992","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109869_bb0120","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9-induced leukemogenesis requires coexpression of the wild-type mll allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1016\/j.bioorg.2026.109869_bb0130","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1182\/blood-2010-12-324699","article-title":"MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109869_bb0135","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2010.05.011","article-title":"Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis","volume":"38","author":"Milne","year":"2010","journal-title":"Mol. Cell"},{"issue":"47","key":"10.1016\/j.bioorg.2026.109869_bb0140","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1038\/sj.onc.1210760","article-title":"Hox genes in hematopoiesis and leukemogenesis","volume":"26","author":"Argiropoulos","year":"2007","journal-title":"Oncogene"},{"issue":"41","key":"10.1016\/j.bioorg.2026.109869_bb0145","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.0503630102","article-title":"MLL associates specifically with a subset of transcriptionally active target genes","volume":"102","author":"Milne","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7591","key":"10.1016\/j.bioorg.2026.109869_bb0150","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature16952","article-title":"Structural basis for activity regulation of MLL family methyltransferases","volume":"530","author":"Li","year":"2016","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109869_bb0165","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1021\/acs.jmedchem.6b01796","article-title":"Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)-mixed lineage leukemia (MLL) protein-protein interaction","volume":"60","author":"Karatas","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109869_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.04.032","article-title":"Structure-based design and synthesis of small molecular inhibitors disturbing the interaction of MLL1-WDR5","volume":"118","author":"Li","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109869_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113677","article-title":"Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity","volume":"223","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109869_bb0175","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1021\/acs.jmedchem.5b01630","article-title":"Structure-based optimization of a small molecule antagonist of the interaction between WD repeat-containing protein 5 (WDR5) and mixed-lineage leukemia 1 (MLL1)","volume":"59","author":"Getlik","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109869_bb0215","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.celrep.2019.02.047","article-title":"Displacement of WDR5 from chromatin by a WIN site inhibitor with picomolar affinity","volume":"26","author":"Aho","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acs.jmedchem.9b01608","article-title":"Discovery and structure-based optimization of potent and selective WD repeat domain 5 (WDR5) inhibitors containing a dihydroisoquinolinone bicyclic core","volume":"63","author":"Tian","year":"2020","journal-title":"J. Med. Chem."},{"issue":"613","key":"10.1016\/j.bioorg.2026.109869_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1578","article-title":"A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models","volume":"13","author":"Yu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109869_bb0155","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/jm100139b","article-title":"Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction","volume":"53","author":"Karatas","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molcel.2013.12.001","article-title":"Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia","volume":"53","author":"Cao","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.109869_bb0170","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.chembiol.2025.10.002","article-title":"Therapeutic targeting of WDR5-MLL1 by EMBOW-derived peptides suppresses leukemia progression","volume":"32","author":"Zhang","year":"2025","journal-title":"Cell. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109869_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20121280","article-title":"Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5","volume":"449","author":"Senisterra","year":"2013","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109869_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/ml300467n","article-title":"Synthesis, optimization, and evaluation of novel small molecules as antagonists of WDR5-MLL interaction","volume":"4","author":"Bolshan","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109869_bb0200","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1021\/acs.jmedchem.1c00091","article-title":"Discovery of DDO-2213 as a potent and orally bioavailable inhibitor of the WDR5-mixed lineage leukemia 1 protein-protein interaction for the treatment of MLL fusion leukemia","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0205","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1021\/acs.jmedchem.4c01720","article-title":"Discovery of WDR5-MLL1 and HDAC dual-target inhibitors for the treatment of acute myeloid leukemia","volume":"68","author":"Long","year":"2025","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.109869_bb0210","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/acs.jmedchem.8b00375","article-title":"Discovery of potent 2-Aryl-6,7-dihydro-5 h-pyrrolo[1,2- a]imidazoles as WDR5-WIN-site inhibitors using fragment-based methods and structure-based design","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109869_bb0225","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1021\/acs.jmedchem.2c00195","article-title":"Discovery of potent orally bioavailable WD repeat domain 5 (WDR5) inhibitors using a pharmacophore-based optimization","volume":"65","author":"Teuscher","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0230","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/acs.jmedchem.3c01463","article-title":"Discovery and optimization of WDR5 inhibitors via cascade deoxyribonucleic acid-encoded library selection approach","volume":"67","author":"Qin","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109869_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211297120","article-title":"Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models","volume":"120","author":"Teuscher","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109869_bb0245","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1021\/acs.jmedchem.5b01984","article-title":"Discovery of potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant staphylococcus aureus (MRSA) infections","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109869_bb0250","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jmedchem.0c02104","article-title":"Discovery of novel plasmodium falciparum HDAC1 inhibitors with dual-stage antimalarial potency and improved safety based on the clinical anticancer drug candidate quisinostat","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109869_bb0255","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1021\/acs.jmedchem.9b01338","article-title":"Development of novel n-hydroxypyridone derivatives as potential anti-ischemic stroke agents","volume":"63","author":"Hu","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109869_bb0260","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.apsb.2023.11.004","article-title":"Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agent","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109869_bb0265","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/106002809703100912","article-title":"Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma","volume":"31","author":"Kelloway","year":"1997","journal-title":"Ann. Pharmacother."},{"issue":"6738","key":"10.1016\/j.bioorg.2026.109869_bb0270","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109869_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.112300","article-title":"WDR5-targeted activatable fluorescent probes for tumor-specific imaging in live cells and in vivo","author":"Chen","year":"2025","journal-title":"Chin. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:36:45Z","timestamp":1778719005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"alternative-id":["S0045206826004050"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109869","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based design of the approved drug zafirlukast identifies HLC40 as a potent WDR5 WIN-site inhibitor with antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109869"}}